Repetitive Transcranial Magnetic Stimulation (rTMS) in The Treatment of Gambling Disorder in Indonesia

Launched by INDONESIA UNIVERSITY · Dec 13, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment approach for people with gambling disorder, specifically focusing on online gambling. Researchers want to see if combining two methods—Repetitive Transcranial Magnetic Stimulation (rTMS) and Cognitive-Behavioral Therapy (CBT)—can help reduce cravings and improve the overall treatment outcomes for individuals struggling with this addiction.

To be eligible for the study, participants should be between 18 and 59 years old, have a gambling problem as identified by a specific scoring system, and be able to understand Bahasa Indonesia. They need to agree to participate in the trial and receive treatment. However, people with certain medical histories, such as severe neurological disorders or who are pregnant, cannot join. If chosen, participants can expect to receive a combination of rTMS and CBT during the trial, which aims to explore a new way to help those affected by gambling addiction.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subjects with pathological gambling (SOGS score ≥ 5)
• • Subjects aged 18-59 years old
• • Subjects who understand Bahasa Indonesia
• • Subjects who agree to participate and receive treatment
• Exclusion Criteria:
• • Subjects with history of psychotic disorder, personality disorder, or sleep disorder according to ICD-11
• • Subjects with history of neurostimulation
• • Subjects with history of medical implant
• • Subjects with history of severe neurological disorder, which causes seizure or loss of consciousness
• • Subjects with intellectual disability
• • Subjects with endocrinological disorders
• • Subjects with contraindication during prior MR or other related procedures
• • Subjects who are currently or expecting pregnancy
• • Subjects with history of substance use in the last 6 months